Connection

Valérie Pourcher to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Valérie Pourcher has written about Antiviral Agents.
Valérie Pourcher
Connection Strength
0.117
Antiviral Agents
  1. Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin. AIDS. 2017 06 01; 31(9):1346-1348.
    View in: PubMed
    Score: 0.066
  2. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
    View in: PubMed
    Score: 0.022
  3. Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198.
    View in: PubMed
    Score: 0.020
  4. Atypical presentation of CMV pneumonia in a heart transplant patient. Med Mal Infect. 2018 03; 48(2):151-153.
    View in: PubMed
    Score: 0.004
  5. High proportion of PD-1-expressing CD4+ T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence. Eur J Immunol. 2017 12; 47(12):2113-2123.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.